Every decade, biology gets a tool that changes everything.
PCR in the 1980s. Sequencing in the 2000s. CRISPR in the 2010s. Foundation models in the 2020s.
The pattern is clear. The intervals are shrinking.
Somewhere right now, a 22-year-old with a laptop is designing a protein that didn't exist yesterday.
No PI. No review. No lab.
This is not a hypothetical. This is Tuesday.
Every generation of scientists thinks they're the ones who will finally understand the cell.
Every generation discovers three new layers of complexity underneath.
This is the first generation with tools that might actually keep up
Sequencing a human genome cost $3 billion in 2003.
Today it costs $200.
The next 20 years won't be about reading DNA cheaper.
They'll be about writing it better.
The company that owns the data layer of biological design will matter more than the company that owns the best model.
Models commoditize. Data compounds.
Every remote surgery generates a full dataset.
Every movement, every decision, every correction.
Whoever owns the most surgical hours owns the next AI surgeon.